Iboga, ibogaine, noribogaine & 18-MC



Jump to:

Page 7 (2017-2018)



Tatalovic et al. (2017). Determining short-term effects on the activity of antioxidant enzymes in the rat uterus: the example of ibogaine. The FEBS Journal.

Brown & Alper (2018). Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes. American Journal of Drug and Alcohol Abuse.

Davis et al. (2018). A mixed-method analysis of persisting effects associated with positive outcomes following ibogaine detoxification. Journal of Psychoactive Drugs.

Farrow et al. (2018). Cytochrome P450 and O-methyltransferase catalyse the final steps in the biosynthesis of the anti-addictive alkaloid ibogaine from Tabernanthe iboga. The Journal of Biological Chemistry.

Gonzalez et al. (2018). Ibogaine acute administration in rats promotes wakefulness, long-lasting REM sleep suppression, and a distinctive motor profile. Frontiers in Pharmacology.

Malcolm, Polanco & Barsuglia (2018). Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine. Journal of Psychoactive Drugs.

Mash (2018). Breaking the cycle of opioid use disorder with Ibogaine. The American Journal of Drug and Alcohol Abuse.

Mash et al. (2018). Ibogaine detoxification transitions opioid and cocaine abusers between dependence and abstinence: Clinical observations and treatment outcomes. Frontiers in Psychology.

Noller, Frampton & Yazar-Klosinski (2018). Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study. American Journal of Drug and Alcohol Abuse.

Oreščanin-Dušić et al. (2018). The effects of ibogaine on uterine smooth muscle contractions: Relation to the activity of antioxidant enzymes. Oxidative Medicine and Cellular Longevity.

Yip & Deng (2018). On the relationship between ibogaine and noribogaine. Clinical Toxicology.